Cargando…

Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy

Detalles Bibliográficos
Autores principales: Bari, Rafijul, Granzin, Markus, Tsang, Kam Sze, Roy, Andre, Krueger, Winfried, Orentas, Rimas, Schneider, Dina, Pfeifer, Rita, Moeker, Nina, Verhoeyen, Els, Dropulic, Boro, Leung, Wing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905181/
https://www.ncbi.nlm.nih.gov/pubmed/31839796
http://dx.doi.org/10.3389/fimmu.2019.02784
_version_ 1783478122726817792
author Bari, Rafijul
Granzin, Markus
Tsang, Kam Sze
Roy, Andre
Krueger, Winfried
Orentas, Rimas
Schneider, Dina
Pfeifer, Rita
Moeker, Nina
Verhoeyen, Els
Dropulic, Boro
Leung, Wing
author_facet Bari, Rafijul
Granzin, Markus
Tsang, Kam Sze
Roy, Andre
Krueger, Winfried
Orentas, Rimas
Schneider, Dina
Pfeifer, Rita
Moeker, Nina
Verhoeyen, Els
Dropulic, Boro
Leung, Wing
author_sort Bari, Rafijul
collection PubMed
description
format Online
Article
Text
id pubmed-6905181
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69051812019-12-15 Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy Bari, Rafijul Granzin, Markus Tsang, Kam Sze Roy, Andre Krueger, Winfried Orentas, Rimas Schneider, Dina Pfeifer, Rita Moeker, Nina Verhoeyen, Els Dropulic, Boro Leung, Wing Front Immunol Immunology Frontiers Media S.A. 2019-12-04 /pmc/articles/PMC6905181/ /pubmed/31839796 http://dx.doi.org/10.3389/fimmu.2019.02784 Text en Copyright © 2019 Bari, Granzin, Tsang, Roy, Krueger, Orentas, Schneider, Pfeifer, Moeker, Verhoeyen, Dropulic and Leung. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bari, Rafijul
Granzin, Markus
Tsang, Kam Sze
Roy, Andre
Krueger, Winfried
Orentas, Rimas
Schneider, Dina
Pfeifer, Rita
Moeker, Nina
Verhoeyen, Els
Dropulic, Boro
Leung, Wing
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
title Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
title_full Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
title_fullStr Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
title_full_unstemmed Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
title_short Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
title_sort corrigendum: a distinct subset of highly proliferative and lentiviral vector (lv)-transducible nk cells define a readily engineered subset for adoptive cellular therapy
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905181/
https://www.ncbi.nlm.nih.gov/pubmed/31839796
http://dx.doi.org/10.3389/fimmu.2019.02784
work_keys_str_mv AT barirafijul corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT granzinmarkus corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT tsangkamsze corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT royandre corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT kruegerwinfried corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT orentasrimas corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT schneiderdina corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT pfeiferrita corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT moekernina corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT verhoeyenels corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT dropulicboro corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy
AT leungwing corrigendumadistinctsubsetofhighlyproliferativeandlentiviralvectorlvtransduciblenkcellsdefineareadilyengineeredsubsetforadoptivecellulartherapy